Users Online: 181
Home
About us
Editorial board
Search
Browse articles
Submit article
Ahead of Print
Instructions
Subscribe
Contacts
Special issues
Login
» Articles published in the past year
To view other articles click corresponding year from the navigation links on the side bar.
All
|
Brief Communication
|
Brief Reports
|
Case Report and Literature Review
|
Case Reports
|
Commentary
|
Editorial
|
Erratum
|
Letter to Editor
|
Letters to Editor
|
Meta Analysis
|
Notice of Retraction
|
Original Article
|
Original Articles
|
Original Empirical Article
|
Research Articles
|
Review Articles
|
Review Report
|
Short Communications
|
Systematic Review
|
Systematic Review and Meta-Analysis
Export selected to
Endnote
Reference Manager
Procite
Medlars Format
RefWorks Format
BibTex Format
Show all abstracts
Show selected abstracts
Export selected to
Add to my list
Case Report:
A Case of Tyrosinemia Type III with Status Epilepticus and Mental Retardation
Reza Najafi, Neda Mostofizadeh, Mahin Hashemipour
Adv Biomed Res
2018, 7:7 (22 January 2018)
DOI
:10.4103/2277-9175.223740
PMID
:29456978
Tyrosinemia type III is an autosomal recessive disorder caused by the deficiency of 4- hydroxyphenylpyruvate dioxygenase (4-HPPD). It is characterized by elevated levels of blood tyrosine and massive excretion of its derivatives into the urine. Clinical findings of tyrosinemia type III include neurological symptoms and mental retardation. Only a few patients presenting with this disease have been described, and the clinical phenotype remains variable and unclear. We present a case, who was admitted to the hospital at the age of 4 months for recurrent seizures. Two months later, she was admitted again with status epilepticus. Laboratory data showed increased level of tyrosine in the blood. She was treated with a diet low in tyrosine and phenylalanine and anamix formula that leading to catch-up growth and improvement of her symptoms. Plasma tyrosine level dropped to normal values. In any child who presents with the neurologic symptom, some rare diagnosis like tyrosinemia type III should be considered.
[ABSTRACT]
[HTML Full text]
[PDF]
[Mobile Full text]
[EPub]
[Citations (9) ]
[PubMed]
[Sword Plugin for Repository]
Beta
Feedback
Subscribe
Advanced Search
Month wise articles
Figures next to the month indicate the number of articles in that month
2023
February
[
2
]
January
[
2
]
2022
December
[
2
]
November
[
1
]
October
[
3
]
August
[
1
]
April
[
2
]
January
[
3
]
2021
December
[
1
]
November
[
1
]
October
[
1
]
September
[
2
]
2020
December
[
1
]
November
[
2
]
September
[
2
]
August
[
4
]
July
[
1
]
June
[
1
]
2019
November
[
1
]
September
[
2
]
May
[
1
]
March
[
1
]
January
[
1
]
2018
December
[
1
]
November
[
1
]
September
[
1
]
July
[
1
]
June
[
2
]
May
[
4
]
April
[
1
]
March
[
2
]
February
[
1
]
January
[
1
]
2017
December
[
2
]
October
[
1
]
August
[
1
]
July
[
2
]
June
[
1
]
May
[
1
]
March
[
2
]
February
[
1
]
2016
December
[
3
]
September
[
1
]
August
[
1
]
April
[
2
]
March
[
4
]
January
[
1
]
2015
August
[
4
]
July
[
1
]
May
[
1
]
March
[
2
]
February
[
5
]
January
[
3
]
2014
December
[
4
]
November
[
3
]
September
[
2
]
August
[
1
]
July
[
1
]
June
[
2
]
March
[
2
]
February
[
1
]
January
[
11
]
2013
November
[
1
]
July
[
2
]
June
[
1
]
March
[
9
]
2012
October
[
2
]
August
[
3
]
July
[
3
]
May
[
3
]
Sitemap
|
What's New
Feedback
|
Copyright and Disclaimer
|
Privacy Notice
© Advanced Biomedical Research | Published by Wolters Kluwer -
Medknow
Online since 15 January, 2012